Preconditioning by Levosimendan is Mediated by Activation of Mitochondrial Ca2+-Sensitive Potassium (mBKCa) Channels-Reference-Cited by-同舟云学术

Preconditioning by Levosimendan is Mediated by Activation of Mitochondrial Ca2+-Sensitive Potassium (mBKCa) Channels

Published:2018-08-17 Issue:5 Volume:32 Page:427-434
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Bunte Sebastian,Behmenburg Friederike,Bongartz Anton,Stroethoff Martin,Raupach Annika,Heinen André,Minol Jan-Philipp,Hollmann Markus W.,Huhn Ragnar,Sixt Stephan U.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://link.springer.com/article/10.1007/s10557-018-6819-5/fulltext.html

Reference36 articles.

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124–36.

2. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet. 1993;342(8866):276–7.

3. Santillo E, Migale M, Postacchini D, Balestrini F, Incalzi RA. Cardioprotection by conditioning mimetic drugs. Antiinflamm Antiallergy Agents Med Chem. 2016;15(1):15–30.

4. Cao CM, Xia Q, Gao Q, Chen M, Wong TM. Calcium-activated Potassium Channel triggers Cardioprotection of ischemic preconditioning. J Pharmacol Exp Ther. 2005;312(2):644–50.

5. Kinoshita M, Tsutsumi YM, Fukuta K, Kasai A, Tanaka K. Isoflurane-induced postconditioning via mitochondrial calcium-activated potassium channels. J Med Investig. 2016;63(1–2):80–4.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of organellar Ca2+-activated K+ channels in disease development;Life Sciences;2023-03

2. Levosimendan: mechanistic insight and its diverse future aspects in cardiac care;Acta Cardiologica;2022-10-12

3. The Coadministration of Levosimendan and Exenatide Offers a Significant Cardioprotective Effect to Isolated Rat Hearts against Ischemia/Reperfusion Injury;Journal of Cardiovascular Development and Disease;2022-08-12

4. The Use of Levosimendan for the Treatment of Heart Failure and its Potential Organoprotective Effects;Rational Pharmacotherapy in Cardiology;2022-05-06

5. The Use of Levosimendan for the Treatment of Heart Failure and its Potential Organoprotective Effects;RATION PHARMACOTHER;2022